Valued at $230.0M at its later-stage round, Dec 2025. Nothing has traded since.
- ·The complete investor list: 21 names
- ·Watch Mediar Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Mediar Therapeutics funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2025 | Early Stage VC | $37.8M | ▮ | ▮ |
| Nov 2022 | Later Stage VC | $85.0M | ▮ | ▮ |
| Jan 2019 | Early Stage VC | $5.0M | ▮ | ▮ |
Membership and data by Private Market View
Mediar Therapeutics valuation
Mediar Therapeutics was valued at $230 million at its later-stage round in Dec 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Mediar Therapeutics raised?
Mediar Therapeutics has raised $180 million across 3 recorded rounds since 2019. The largest was an $85 million later-stage round in Nov 2022; the most recent was a $37.8 million early-stage round in Dec 2025.
Mediar Therapeutics has filed 4 Form Ds with the SEC since 2019, most recently in Oct 2024 ($85 million sold to 17 investors).
How Mediar Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Mediar Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Mediar Therapeutics
- What is Mediar Therapeutics worth?
- Mediar Therapeutics is valued at $230.0M as of Oct 2026. Valued at $230.0M at its later-stage round, Dec 2025. Nothing has traded since.
- How much has Mediar Therapeutics raised?
- Mediar Therapeutics has raised $180.3M in total funding across 3 recorded rounds.
- When did Mediar Therapeutics last raise?
- Mediar Therapeutics last raised in Dec 2025 (Early Stage VC), raising $37.8M.